NCT00564213View on ClinicalTrials.gov

Evaluation of the Prophylactic Use of Mitomycin C 0.02% to Inhibit Haze Formation After Photorefractive Keratectomy for High Myopia: 15 x 30 Seconds

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

September 30, 2007

Conditions
High Myopia
Interventions
DRUG

PRK and a single intraoperative topical application of mitomycin C 0.02% for 15 seconds

Mitomycin 0.02%

All Listed Sponsors
lead

Instituto de Olhos de Goiania

OTHER

NCT00564213 - Evaluation of the Prophylactic Use of Mitomycin C 0.02% to Inhibit Haze Formation After Photorefractive Keratectomy for High Myopia: 15 x 30 Seconds | Biotech Hunter | Biotech Hunter